Results of an epidemiological study found that there was no increased risk of suicidality with aripiprazole compared to other antipsychotics among patients with bipolar disorder.
Epidemioloogilises uuringus ei ilmnenud bipolaarse meeleoluhäirega patsientidel suitsidaalsuse riski suurenemist aripiprasooliga võrreldes teiste antipsühhootikumidega.